4.5 Article

High expression of CLEC10A in head and neck squamous cell carcinoma indicates favorable prognosis and high-level immune infiltration status

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma

Jameel Muzaffar et al.

Summary: Head and neck squamous cell carcinoma (HNSCC) is the most common cancer in the head and neck region, with smoking, excessive drinking, and HPV infection as the main risk factors. While the prognosis of non-metastatic HNSCC continues to improve, the treatment of metastatic disease remains challenging.

CANCERS (2021)

Article Cell Biology

CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma

Min He et al.

Summary: Lower expression of CLEC10A in LUAD patients is associated with worse outcomes, and its expression is significantly correlated with various tumor-infiltrating immune cells. Therefore, CLEC10A may be a promising prognostic indicator and immunotherapy target for LUAD.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Multidisciplinary Sciences

Identification of P2RY13 as an immune-related prognostic biomarker in lung adenocarcinoma: A public database-based retrospective study

Jiang Lin et al.

Summary: This study used gene matrixes to infer immune and stromal scores in LUAD and identified 303 immune-related DEGs. Univariate Cox regression and survival analysis revealed P2RY13 as a favorable prognostic factor in LUAD, highly correlated with various TIICs and immune functions. Several immune-associated pathways were enriched between high and low expression of P2RY13 groups.
Article Oncology

High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancer

Gerardo Gatti et al.

Summary: Background characterization of breast cancer includes markers such as ER, PR, HER2, and Ki67. Tumor-infiltrating lymphocytes are considered in certain BC subtypes. Additional biomarkers, such as IRF8, are being explored to improve precision in therapeutic response.

BREAST CANCER RESEARCH (2021)

Review Oncology

Human papillomavirus as a driver of head and neck cancers

Maria Elisa Sabatini et al.

BRITISH JOURNAL OF CANCER (2020)

Review Dentistry, Oral Surgery & Medicine

Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma

Zi Mei et al.

INTERNATIONAL JOURNAL OF ORAL SCIENCE (2020)

Article Immunology

Cancer cell CCR2 orchestrates suppression of the adaptive immune response

Miriam R. Fein et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Article Medicine, General & Internal

Head and neck squamous cell carcinoma

Daniel E. Johnson et al.

NATURE REVIEWS DISEASE PRIMERS (2020)

Review Oncology

Immunotherapy for squamous cell carcinoma of the head and neck

Tomoya Yokota et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2020)

Review Oncology

Translational Research: A Future Strategy for Managing Squamous Cell Carcinoma of the Head and Neck?

F. Caponigro et al.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2018)

Article Multidisciplinary Sciences

Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance

Melissa A. Meyer et al.

NATURE COMMUNICATIONS (2018)

Article Biochemistry & Molecular Biology

Maftools: efficient and comprehensive analysis of somatic variants in cancer

Anand Mayakonda et al.

GENOME RESEARCH (2018)

Article Medicine, Research & Experimental

Frameshift events predict anti-PD-1/L1 response in head and neck cancer

Glenn J. Hanna et al.

JCI INSIGHT (2018)

Review Oncology

Checkpoint Inhibitors in Head and Neck Cancer: Rationale, Clinical Activity, and Potential Biomarkers

Panagiota Economopoulou et al.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)

Article Otorhinolaryngology

Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma

Nghia Nguyen et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)

Article Biochemistry & Molecular Biology

Dual Roles of Group IID Phospholipase A2 in Inflammation and Cancer

Yoshimi Miki et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Article Oncology

FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas

Jun Yan et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Article Oncology

FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas

Jun Yan et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Review Oncology

Immunity in Head and Neck Cancer

Jonathan D. Schoenfeld

CANCER IMMUNOLOGY RESEARCH (2015)

Review Otorhinolaryngology

Clinical relevance of immune parameters in the tumor microenvironment of head and neck cancers

Sebastian P. Wallis et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)

Editorial Material Oncology

The dual role of IRF8 in cancer immunosurveillance

Giovanna Schiavoni et al.

ONCOIMMUNOLOGY (2013)

Article Immunology

Targeting of macrophage galactose-type C-type lectin (MGL) induces DC signaling and activation

Chiara Napoletano et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2012)

Article Medicine, General & Internal

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

K. Kian Ang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Immunology

MGL-mediated internalization and antigen presentation by dendritic cells: A role for tyrosine-5

Sandra J. van Vliet et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2007)

Article Multidisciplinary Sciences

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

A Subramanian et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Biochemical Research Methods

limmaGUI: A graphical user interface for linear modeling of microarray data

JM Wettenhall et al.

BIOINFORMATICS (2004)